K-ras mutation detection by hybridization to a polypyrrole DNA chip

被引:0
|
作者
Lopez-Crapez, E
Livache, T
Marchand, J
Grenier, J
机构
[1] Ctr Rech Cancerol, CLRC Val dAurelle Paul Lamarque, F-34298 Montpellier 5, France
[2] CIS Bio Int, F-91192 Gif Sur Yvette, France
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Detection of mutations in cancer-related genes is of major importance for both basic knowledge and clinical practice. Several strategies have been developed to diagnose these alterations. We describe a method based on polypyrrole DNA chip technology to detect K-ras gene mutations in tumors. Methods: An oligodeoxynucleotide array was constructed on a silicon device by copolymerization of 5'-pyrrole-labeled oligodeoxynucleotides and pyrrole. The samples to be analyzed were then amplified by PCR, and the single-stranded biotin-labeled amplified DNA was specifically hybridized to the addressed probes. Perfectly matched duplexes were detected by fluorescence microscopy using R-phycoerythrin as the detection label. The developed methodology was applied to genotype assignment of K-ras in human samples. The genotypes of 75 DNA genomic samples from colorectal cancer patients were analyzed side by side using direct DNA sequencing and a polypyrrole DNA chip. Results: The chip method unequivocally defined all of the genotypes. Mutations present at <10% of the wild-type DNA concentration could be distinguished. Conclusions: This probe array assay is a rapid and reliable procedure that may be used to detect mutations. (C) 2001 American Association for Clinical Chemistry.
引用
收藏
页码:186 / 194
页数:9
相关论文
共 50 条
  • [21] K-ras activation and oxidative DNA damage
    Kawanishi, S.
    Ohnishi, S.
    Saito, H.
    Suzuki, N.
    Hiraku, Y.
    Murata, M.
    FREE RADICALS, HEALTH AND LIFESTYLE, 2009, : 75 - +
  • [22] Frequency of K-ras mutation in biliary and pancreatic tumors
    Roa, JC
    Anabalón, L
    Tapia, O
    Melo, A
    de Aretxabala, X
    Roa, I
    REVISTA MEDICA DE CHILE, 2005, 133 (12) : 1434 - 1440
  • [23] K-RAS MUTATION IN PRIMARY RETROPERITONEAL MUCINOUS CYSTOADENOCARCINOMA
    TENTI, P
    ROMAGNOLI, S
    PELLEGATA, NS
    SILINI, E
    GIANATTI, A
    GIUNTA, P
    ROSSO, R
    MAGRINI, U
    CARNEVALI, L
    LABORATORY INVESTIGATION, 1993, 68 (01) : A79 - A79
  • [24] K-RAS MUTATION IN COLORECTAL CARCINOMAS FROM SINGAPORE
    PHANG, TW
    SHI, CY
    WEE, A
    NGOI, SS
    LI, B
    LEE, HP
    ONG, CN
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (01) : 191 - 195
  • [25] K-ras mutation in colorectal cancer treated with cetuximab
    Barbareschi, M.
    Girlando, S.
    Soini, B.
    Cuorvo, L.
    Fasanella, S.
    Cantaloni, C.
    Piccolo, A.
    Prosdocimi, F.
    Galligioni, E.
    Dalla Palma, P.
    VIRCHOWS ARCHIV, 2009, 455 : 396 - 396
  • [26] Biochip for K-ras mutation screening in ovarian cancer
    Fabjani, G
    Kriegshaeuser, G
    Schuetz, A
    Prix, L
    Zeillinger, R
    CLINICAL CHEMISTRY, 2005, 51 (04) : 784 - 787
  • [27] K-RAS mutation in the screening, prognosis and treatment of cancer
    Parsons, Barbara L.
    Meng, Fanxue
    BIOMARKERS IN MEDICINE, 2009, 3 (06) : 757 - 769
  • [28] K-RAS GENE MUTATION IN INTRADUCTAL NEOPLASMS THE PANCREAS
    SESSA, F
    CAPELLA, C
    KLOPPEL, K
    ZAMBONI, G
    SCARPA, A
    BONATO, M
    SOLCIA, E
    RANZANI, GN
    LABORATORY INVESTIGATION, 1994, 70 (01) : A135 - A135
  • [29] K-ras mutations in lung cancer: The "mysterious mutation"
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2006, 8 (01) : 11 - 12
  • [30] Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
    Kopreski, MS
    Benko, FA
    Kwee, C
    Leitzel, KE
    Eskander, E
    Lipton, A
    Gocke, CD
    BRITISH JOURNAL OF CANCER, 1997, 76 (10) : 1293 - 1299